
International Business Times AU
5,458 FOLLOWERS
International Business Times (IBTimes) is a growing digital global news publication that delivers international business news. IBTimes provides comprehensive content around the most important business, economic and political stories from around the world, while also adhering to other niche areas that interest global readers.
20 Trucks Of Wounded Russian Soldiers Arrive At Hospital In 24 Hours Amid Aggressive Ukraine Defense
International Business Times AU
10h ago
Russia continues accumulating casualties on the Ukrainian battlefield in the ongoing war ..read more
International Business Times AU
10h ago
Working memory, the neurological function mainly targeted by Cogmed and one of the core aspects of intelligence ..read more
International Business Times AU
10h ago
The lawsuits against Binance and Coinbase, according to the SEC chairman, took a while to produce due to the amount of work required ..read more
International Business Times AU
10h ago
A Chinese Embassy official insists that the maritime dispute in the South China Sea doesn't define the bilateral relations between China and the Philippines ..read more
International Business Times AU
10h ago
Fresh from enjoying recent success on the football pitch, Manchester City have achieved a significant milestone away from all the action ..read more
International Business Times AU
10h ago
A study published by the Environmental Research Journal suggests the positive impact that green spaces in urban areas can have on mental health ..read more
International Business Times AU
10h ago
The drug is especially crucial for people with a BRCA gene mutation, a mutation branded as the "Jolie gene ..read more
International Business Times AU
10h ago
A crypto wallet is an application that enables users to store keys that access cryptocurrency through a blockchain. You'll also hear the term digital wallet used interchangeably with crypto wallet ..read more
International Business Times AU
17h ago
MELBOURNE, Australia--(BUSINESS WIRE)--Propanc Biopharma, Inc. (OTC Pink: PPCBD) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, today announced the Company’s strategic pharma partnering initiative, as its lead product candidate, PRP, advances towards a Phase I, First-In-Human (FIH) study in advanced cancer patients. Over the past several years, management has initiated discussions with potential strategic collaborators to provide the resources to advance PRP into clinical development and ..read more
International Business Times AU
17h ago
Removing the burden from its customers' security teams, Obsidian seamlessly rolls out and integrates apps into existing SaaS postures ..read more